These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30055097)

  • 21. Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis.
    Dekeyser C; De Kesel P; Cambron M; Vanopdenbosch L; Van Hijfte L; Vercammen M; Laureys G
    Front Immunol; 2024; 15():1385231. PubMed ID: 38745673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.
    Duell F; Evertsson B; Al Nimer F; Sandin Å; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32527760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
    J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study.
    Hegen H; Berek K; Cavalla P; Christiansen M; Emeršič A; Di Filippo M; Gaetani L; Hassler M; Leurs C; Milosavljevic D; van Pesch V; Petersen T; Presslauer S; Rosenstein I; Rot U; Schnabl C; Teunissen C; Vecchio D; Vercellino M; Deisenhammer F
    Front Immunol; 2023; 14():1327947. PubMed ID: 38169789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing.
    Süße M; Feistner F; Holbe C; Grothe M; Nauck M; Dressel A; Hannich MJ
    Clin Chim Acta; 2020 Aug; 507():205-209. PubMed ID: 32353362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
    Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
    Hegen H; Berek K; Deisenhammer F
    Wien Med Wochenschr; 2022 Nov; 172(15-16):337-345. PubMed ID: 35133530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.
    Desplat-Jégo S; Feuillet L; Pelletier J; Bernard D; Chérif AA; Boucraut J
    J Clin Immunol; 2005 Jul; 25(4):338-45. PubMed ID: 16133990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa free light chains: Diagnostic performance in multiple sclerosis and utility in a clinical laboratory.
    Alves Martins D; Lopes J; Martins da Silva A; Morais CI; Vasconcelos J; Lima I; Carneiro C; Neves E
    Clin Chim Acta; 2022 Mar; 528():56-64. PubMed ID: 35092724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases.
    Michetti L; Maffina F; Ravasio R; Barcella V; Radaelli M; Chiudinelli L; Sessa M; Alessio MG
    J Neuroimmunol; 2023 Jun; 379():578091. PubMed ID: 37210840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
    Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
    PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of measles-rubella-zoster reaction, oligoclonal IgG bands, oligoclonal kappa free light chains and kappa index in multiple sclerosis.
    Zondra Revendova K; Svub K; Bunganic R; Pelisek O; Volny O; Ganesh A; Bar M; Zeman D; Kusnierova P
    Mult Scler Relat Disord; 2024 Jan; 81():105125. PubMed ID: 37980789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.
    Feki S; Damak M; Sakka S; Ben Ali Y; Mejdoub S; Bouattour N; Hachicha H; Mhiri C; Masmoudi H
    Sci Rep; 2022 Sep; 12(1):16425. PubMed ID: 36180495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis: use of light-chain typing to assist diagnosis.
    Jenkins MA; Cheng L; Ratnaike S
    Ann Clin Biochem; 2001 May; 38(Pt 3):235-41. PubMed ID: 11392498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.
    Vasilj M; Kes VB; Vrkic N; Vukasovic I
    Clin Neurol Neurosurg; 2018 Nov; 174():220-229. PubMed ID: 30278299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.
    Goffette S; Schluep M; Henry H; Duprez T; Sindic CJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):308-10. PubMed ID: 14742614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands.
    Altinier S; Puthenparampil M; Zaninotto M; Toffanin E; Ruggero S; Gallo P; Plebani M
    Clin Chim Acta; 2019 Sep; 496():117-120. PubMed ID: 31233736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal immunoglobulin synthesis: The potential value of an adjunct test.
    Emersic A; Anadolli V; Krsnik M; Rot U
    Clin Chim Acta; 2019 Feb; 489():109-116. PubMed ID: 30529605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.
    Rathbone E; Durant L; Kinsella J; Parker AR; Hassan-Smith G; Douglas MR; Curnow SJ
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1044-1049. PubMed ID: 29743290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.